Similarly, a 2017 double-blind, placebo-controlled trial found that oral administration of ALA (1,200 mg/day) for eight weeks induced mild weight loss accompanied by a reduction in waist circumference
(10) Engel MG, Narayan S, Cui MH, Branch CA, Zhang X, Gandy SE, Ehrlich M, Huffman DM
Note: To support and expand your research on sleep peptides and neurological function, explore our dedicated selection of Nasal Sprays
Overall, retatrutides early data paints the picture of an exciting future treatment that could help patients achieve weight loss on a scale previously seen only with surgery
Semaglutide is generally not used during pregnancy or breastfeeding, in people with the thyroid or MEN 2 history above, with a history of pancreatitis, or with certain other conditions